Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1021 of 1,261

  1. US 7604811

    Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres

    The United States of America as represented by the Secretary of the Army · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  2. TW 200942531

    Crystal forms of a nitrocatechol

    BIAL PORTELA & COMPANHIA S A [PT] · Granted Oct 16, 2009 · Expires Oct 11, 2029

    granted

  3. US 7601717

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  4. US 7601718

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  5. US 7601731

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  6. US 7601735

    Antiviral compounds

    Airgain, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  7. US 7601840

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  8. US 7601490

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  9. US 7601690

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  10. US 7601740

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  11. US 7601355

    Compositions and methods for altering immune function

    Northwestern University · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  12. US 7601683

    Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  13. US 7601868

    Amine derivative

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  14. US 7601802

    Cysteine-containing peptides having antioxidant properties

    The Regents of the University of California · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  15. US 7601114

    Apparatus and method for enhancing tissue repair in mammals

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  16. US 7601516

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility

    Syntonix Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  17. US 7601713

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  18. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  19. US 7598225

    Generation of immune response to prostate-specific antigen (PSA)

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  20. US 7598418

    Amide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  21. US 7598412

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  22. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  23. US 7598356

    Method for purifying a protein of the cystine-knot superfamily

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  24. US 7598338

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.